Posts

Showing posts from October, 2022

Why Is BPH Treatment Drug and Surgery Demand Rising Notably?

Image
According to the United Nations Department of Economic and Social Affairs (UNDESA), the number of people aged 65 years or more will grow from 727 million in 2020 to around 1.5 billion by 2050.  The U.S. Census Bureau forecasts that the global population of men aged 55–59 years will reach 222,508,188; men within the age group 60–64 years will rise to 198,506,354; and men in the age bracket 65–69 years will surge to 160,741,527 by 2030.  As elderly men are highly vulnerable to benign prostatic hyperplasia (BPH), the surging population of geriatric men will help the benign prostatic hyperplasia treatment market flourish during 2021–2030. According to P&S Intelligence, the market revenue will surge from about $10 billion in 2020 to around $17 billion by 2030. BPH or prostate gland enlargement occurs due to bladder or prostate cancer, kidney or bladder stones, urinary tract infections (UTI), scarring in the bladder neck caused due to previous surgeries, urethral stricture, and prostatit

Topical Scar Treatment Market To Generate $1,451.1 Million Revenue by 2030

Image
A number of factors such as the increasing incidence of burns, growing disposable income, burgeoning geriatric population, rising cases of road accidents, and growing prevalence of skin diseases will help the topical scar treatment market exhibit a CAGR of 7.7% during 2021–2030. According to P&S Intelligence, the market revenue stood at $701.6 million in 2020, and it will reach $1,451.1 million by 2030. In recent years, the burgeoning demand for silicone-based scar treatment products has become a prominent industry trend. The rising prevalence of burn injuries is one of the primary growth drivers of the market, as scars are often formed due to skin damage caused owing to burns. According to the WHO, approximately 180,000 burn-related deaths are caused every year, globally. Nearly two-thirds of these deaths are recorded in the African and SEA regions. As per an article published in the Experimental and Therapeutic Science Journal in April 2019, over 10 million people in China suffer